RAMM Pharma Announces Approval and Registration of Epifractán™ 2 Percent by Peru’s Ministry of Health Pharmaceutical Investing
POSaBIT CEO Ryan Hamlin: Mobile Point-of-Sale Device Could Improve Retail Safety Standards Cannabis Investing News
RAMM Pharma Announces Approval and Registration of Epifractán™ 5 Percent by Peru’s Ministry of Health and Enters Distribution Agreement to Supply Pharmacies in Peru Pharmaceutical Investing
BioHarvest Sciences: Developing Disruptive Biofarming Technology for the Cannabis Industry Technology Investing News